A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

Hernán, Miguel A., Takkouche, Bahi, Caamaño‐Isorna, Francisco, Gestal‐Otero, Juan J.·2002·Annals of Neurology
DOI 10.1002/ana.10277

Cited by (817)

Items 701–800 of 817

  1. Prognostic factors associated with disease progression in parkinson's disease
    Leslie Wayne Ferguson · 2005 · University Library - University of Saskatchewan (University of Saskatchewan)
  2. Occupational exposure to extremely low frequency magnetic fields and the risk of chronic diseases
    Tom Koeman · 2014 · Utrecht University Repository (Utrecht University)
  3. Dietary parp-1 inhibitors as anti-inflammatory compounds
    Liesbeth Geraets · 2008
  4. Natural Health Products in Parkinson Disease
    Cheryl A Sadowski, Shirley Heschuk · 2010 · Health care and disease management
  5. Influence of Neurological Medication on Nutritional Status
    Marianne Aloupis, Ame L. Golaszewski · 2009 · Humana Press eBooks
  6. An Investigation into Household and Occupational Pesticide Exposures with Genetic Variants as Risk Factors for Parkinson's Disease
    Shilpa Narayan · 2015 · eScholarship (California Digital Library)
  7. Synucleins in the midbrain dopaminergic system : the role in health and disease
    Natalie Connor‐Robson · 2013 · ORCA Online Research @Cardiff (Cardiff University)
  8. Einfluss des GDNF-Rezeptors Ret auf die Erholung des nigrostriatalen Systems im MPTP-Mausmodell der Parkinsonerkrankung
    Charlotte Pöppelmeyer · 2011
  9. Role of Trichloroethylene in Parkinson’s Disease
    Samuel M. Goldman, Stephanie Whisnant Cash · 2014 · Molecular and integrative toxicology
  10. Kaffee gegen Morbus Parkinson?
    Holger Stark · 2006 · Pharmazie in unserer Zeit
  11. Tabac
    John C.M. Brust · 2007 · Elsevier eBooks
  12. La cafeína en la enfermedad de Parkinson
    Sergi Ferré · 2008 · Medicina Clínica
  13. Occupational exposures to magnetic fields and neurodegenerative disease risks
    Harvey Checkoway · 2007 · Occupational and Environmental Medicine
  14. Mechanisms of aluminium neurotoxicity in oxidative stress-induced degenerative processes in relation to parkinson's disease
    Sofía Sánchez Iglesias · 2011 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  15. Environmental Epidemiology of Sporadic Parkinson�s Disease
    Honglei Chen, Xuemei Huang · 2010 · North American Journal of Medicine and Science
  16. THE PROTECTIVE ROLE OF NRF2/KEAP1 IN NEUROLOGICAL DISEASE AND OXIDATIVE STRESS-INDUCED CELL DAMAGE
    Petra Bergström · 2013 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  17. Does Cigarette Smoking Have a Protective Effect Against Parkinson's Disease?
    Seyed Ali Masoud · 2008 · Iranian Journal of Psychiatry and Behavioral Sciences
  18. An investigation into the role of mitochondrial dysfunction in South African Parkinson’s disease patients
    Celia van der Merwe · 2012 · SUNScholar (Stellenbosch University)
  19. CONFIDENTIAL DRAFT Survival analysis; risk sets; matched case control studies: a unified view of some epidemiologic data-analyses. Part I
    James A. Hanley · 2004
  20. Aus dem Zentrum für Neurologie
    Ärztlicher Direktor, Thomas Gasser · 2010
  21. EFFECT OF pH AND TEMPERATURE ON THE BINDING INTERACTIONS OF CAFFEINE AND CHLOROGENIC ACID WITH SODIUM CASEINATE
    Emily S. Kong · 2013
  22. Identification of parkin interactions: implications for Parkinson’s disease
    William Lloyd Haylett · 2015 · SUNScholar (Stellenbosch University)
  23. EFECTO DE LA ADMINISTRACIÓN CRÓNICA DE LEVODOPA SOBRE LA ACTIVIDAD FUNCIONAL DE LA VÍA NIGROESTRIADA EN MACACOS CON PARKINSONISMO INDUCIDO POR MPTP
    Mario Riverol Fernández · 2010
  24. Nicotine Prevents MPTP-induced Dopaminergic Neurodegeneration
    Jong‐Min Kim, Jeong Ja O, Beom Seok Jeon · 2008 · Experimental Neurobiology
  25. Chewing gum and Woodbines: The comforts of war
    Peter W. Nolan · 2016 · British Journal of Mental Health Nursing
  26. Are umbrella terms for rare genetic diseases still useful?
    Alexandra Dürr · 2016 · Nature Reviews Neurology
  27. ENVIRONMENTAL PERSPECTIVES ENVIRONMENTAL PERSPECTIVES
    Jeff M. Bronstein, Paul M. Carvey, Honglei Chen, Deborah A. Cory‐Slechta, Donato A. Di Monte, John E. Duda, Paul B. English, Samuel M. Goldman, Stephen J. Grate, Johnni Hansen et al. · 2008
  28. evidence from a multicentre case-control study on the risk of primary late-onset blepharospasm: Influence of coffee drinking and cigarette smoking
    M. S. Aniello, Laura Avanzino, Maria Buccafusca, Giovanni Majorana, Carlo Trompetto, P G Defazio, Davide Martino, Giovanni Abbruzzese, Paolo Girlanda, Michèle Tinazzi et al. · 2007
  29. Nitric Oxide Synthase, Green Tea Catechins and Parkinson’s Disease
    Ji Seon Kim, Eungseok Oh, Jong Min Kim · 2012 · Tea in Health and Disease Prevention
  30. Reactive dopamine metabolites and neurotoxicity
    Brigitte Vanle, Jonathan A. Doorn, Michael W. Duffel, Daniel M. Quinn, David L. Roman, Robert J. Kerns · 2016
  31. Studies of interactions of STIM1 and GPCRs with their binding partners
    Jonathan Guan Zhong How · 2015
  32. A Role for Nicotine in Neuroprotection Against Disorders Associated With Monoaminergic and Cognitive Dysfunction
    de Lima Vieira Brock, Paula · 2019 · J. Willard Marriott Library
  33. Epidemiological Methods for Studying Movement Disorders
    Yoav Ben‐Shlomo · 2017 · Springer eBooks
  34. An investigation into the postural control and balance of people with Parkinson's disease and possible therapeutic approaches to improve their postural instability and balance confidence
    Liam G Johnson · 2012 · UWA Profiles and Research Repository (UWA)
  35. Green Tea confers Protection on the Retina in MPTP Mice Model of Parkinson’s Disease
    Philemon Dauda Shallie, Kanyinsola Koya, Oluwadamilola Faith Shallie, Omowumi Moromoke Femi-Akinlosotu, Oluwole Ojo Alese, Margaret Olutayo Alese · 2017 · Annual Research & Review in Biology
  36. Studying the Prevalence and Genetic Contributions to Parkinsonism in Pakistan
    Suliman Khan · 2016 · Griffith Research Online
  37. Heart-Fatty Acid Binding Protein und α-Synuklein im Serum als mögliche Markerkandidaten für Parkinson und Demenz
    Willner, Markus · 2018
  38. Study of Autonomic Nervous System Dysfunction in Parkinson’s Patients.
    E Arunraj · 2013
  39. Analysis of a murine Pink1 deficiency in serotonergic and dopaminergic neurons in respect of Parkinson´s disease
    Angelika Hummel · 2018
  40. Ensemble Statistical Modelling of Risk Factors in Health
    Aleysha Thomas · 2018 · Queensland University of Technology
  41. Towards the differential evaluation of Parkinson’s Disease by means of voice and speech processing
    Laureano Moro-Velázquez · 2018
  42. Influence of Dietary Constituents on Motor and Non-motor Symptoms in Parkinson’s Disease
    Matthias Löhle, Heinz Reichmann · 2014 · Neuropsychiatric symptoms of neurological disease
  43. Coffee: Does it Make Things Better?
    Gurmeet Singh Sarla · 2019 · Zenodo (CERN European Organization for Nuclear Research)
  44. Tobacco
    John C.M. Brust · 2004 · Elsevier eBooks
  45. An Ensemble Approach to Modelling the Combined Effect of Risk Factors on Age at Parkinson’s Disease Onset
    Aleysha Thomas, Paul Pao‐Yen Wu, Nicole Marie White, Leisa-Maree Leontjew Toms, George D. Mellick, Kerrie Lee Mengersen · 2020 · Lecture notes in mathematics
  46. Studies on the Etiology of Parkinson's disease
    Camilla Fardell · 2020 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  47. Der Einfluss von humanem α-Synuclein-Wildtyp und der Mutanten A30P und A53T auf die Autophagie und den Transport synaptischer Vesikel in primären Mittelhirnneuronen der Ratte
    Florian Bitow · 2020
  48. Der Einfluss von humanem Wildtyp-Alpha-Synuclein und seinen Mutationen A30P und A53T auf das Neuritenwachstum primärer dopaminerger Mittelhirnneurone der Ratte
    Jessica Franziska Haack · 2021
  49. Funktionelle Charakterisierung einer neuen Proteininteraktion zwischen Parkin und BAG1
    Schünemann, Julia · 2012
  50. Efecto de la borra de café sobre la biológica espermática: aproximación in vitro
    Brayan Alexander Rojas Mesa, Walter D. Cardona Maya · 2020 · Revista chilena de obstetricia y ginecología
  51. Modulation of neuronal function by tau, alpha synuclein or carbon dioxide
    Emily Hill · 2026 · Warwick Research Archive Portal (University of Warwick)
  52. Epidemiology
    Raymond Y. Lo, Caroline M. Tanner · 2013 · Neurological disease and therapy
  53. Therapeutic and Diagnostic Agents for Parkinson's Disease
    Ola M. Ghoneim, Raymond G. Booth · 2021 · Burger's Medicinal Chemistry and Drug Discovery
  54. Movement Disorders
    Mary E. Jenkins, Janis M. Miyasaki, Oksana Suchowersky · 2011 · Springer eBooks
  55. Nervous System
    Leo F. McCluskey, Ame L. Golaszewski · 2006 · CRC Press eBooks
  56. Peer Review #2 of "The neuroprotective effect of nicotine in Parkinson’s disease models is associated with inhibiting PARP-1 and caspase-3 cleavage (v0.1)"
    2017 · PeerJ
  57. Parkinson's disease
    Jiang‐Fan Chen · 2012 · Cambridge University Press eBooks
  58. References
    2018 · Elsevier eBooks
  59. Faculty Opinions recommendation of β2-adrenoreceptor medications and risk of Parkinson disease.
    Joseph J. Jankovic, Arjun Tarakad · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  60. Peer Review #1 of "The neuroprotective effect of nicotine in Parkinson’s disease models is associated with inhibiting PARP-1 and caspase-3 cleavage (v0.1)"
    2017 · PeerJ
  61. Coffee
    Iziar A. Ludwig, Michael Newton Clifford, Michael E. J. Lean, Alan Crozier · 2016 · Nutraceutical science and technology
  62. Bibliography
    Lucio Guido Costa, David L. Eaton · 2005 · Wiley eBooks
  63. Nano-Structure Studies of Perhydropolysilazane - Derived Silica Thin Layers
    Tomotake Niizeki, Yoshio Hasegawa, Kazuhiro Akutsu-Suyama · 2021 · Vide Leaf, Hyderabad eBooks
  64. パーキンソン病の原因・治療について
    Taku Hatano · 2010 · Juntendō Igaku/Juntendo igaku
  65. Caffeine and Parkinson’s Disease
    Alberto Ascherio, Michael A. Schwarzschild · 2004 · Nutrition, brain, and behavior./Nutrition, brain and behavior
  66. Syndromes parkinsoniens
    Philippe Couratier · 2022 · Elsevier eBooks
  67. Epidemiology
    Roger L. Albin · 2022 · Oxford University Press eBooks
  68. Parkinson’s Disease - Animal Models, Current Therapies and Clinical Trials
    Sarat Chandra Yenisetti, Zevelou Koza, Devendra Kumar, Sushil Kumar Singh, Ankit Ganeshpurkar · 2022 · IntechOpen eBooks
  69. An Update on Premorbid Personality Traits and Brain Recovery: Another Aspect of Resilience
    Daniela Laricchiuta, Eleonora Picerni, Sebastian A. Markett, Martin Reuter, Christian Montag · 2023 · Contemporary clinical neuroscience
  70. Avaliação morfológica e funcional da retina de pacientes com doença de Parkinson usando a tomografia de coerência óptica e o eletrorretinograma
    Luiz Guilherme Marchesi Mello · 2023
  71. ՊԱՐԿԻՆՍՈՆԻ ՀԻՎԱՆԴՈՒԹՅԱՄԲ ԲՈՒԺԱՌՈՒՆԵՐԻ ՇԱՐԺՈՂԱԿԱՆ ԽԱՆԳԱՐՈՒՄՆԵՐԻ ԽՈՐԱՑՈՒՄԸ` ՊԱՅՄԱՆԱՎՈՐՎԱԾ ՆԻԿՈՏԻՆԻ (ԾԽԱԽՈՏԻ) ԸՆԴՈՒՆՄԱՆ ԴԱԴԱՐԵՑՄԱՄԲ
    N.L. Arakelyan, A.A. Kesoyan., D.A. Aloyan, Hovhannes M. Manvelyan · 2023 · MEDICINE SCIENCE AND EDUCATION
  72. GASTROINTESTINAL MUCOSAL DAMAGE AND SUBSEQUENT RISK OF PARKINSON’S DISEASE
    Jocelyn J. Chang, Subhash Kulkarni, Trisha Satya Pasricha · 2024 · medRxiv
  73. References
    2024 · Elsevier eBooks
  74. Inflammatory Roads to Parkinson’s Disease
    Hymie Anisman, Shawn P. Hayley, Alexander Kusnecov · 2024 · Elsevier eBooks
  75. Parkinson disease and Parkinsonism
    Michael Thomas Hayes · 2024 · Elsevier eBooks
  76. Association of Vascular Risk Factors with the Risk of Parkinson’s Disease among Stroke Survivors—A Nationwide Population-Based Study
    Seo Yeon Yoon, Hyun Im Moon, Jin‐Hyung Jung, Sang Chul Lee, Kyungdo Han, Yong Wook Kim · 2024 · medRxiv
  77. Drinking Coffee and Tea and the Prevention of Cancer
    Peter Hofland · 2024 · Onco Zine - The International Oncology Network
  78. Restrictive Lung Disease from Parkinson’s Disease Rigidity
    Shilpa C. Rao · 2025
  79. Health Impacts of Smoking
    Mohd Hafyzuddin Md Yusuf, Siti Nuraliyah Zambri, Nur Amani Ahmad Tajuddin, Farizah Mohd Hairi · 2025 · IntechOpen eBooks
  80. Épidémiologie descriptive et étiologique
    Alexis Elbaz, Fanny Artaud, Cloé Domenighetti, Mariem Hajji, Thi Thu Ha Nguyen, Berta Portugal, Frédéric Moisan · 2025 · Elsevier eBooks
  81. Épidémiologie
    Virginie Chrysostome, François Tison · 2020 · Elsevier eBooks
  82. Stimulants
    Ryan Graddy, Darius A. Rastegar · 2025 · Oxford University Press eBooks
  83. Delirium, genetic susceptibility and Parkinson’s disease progression: a community- and UK biobank–based matched cohort study
    Mengjie Li, Wen Duan, Yanmei Feng, Zhiyun Wang, Xiaoyan Hao, Shuangjie Li, Shilei Sun, Changhe Shi · 2025 · Aging & Mental Health
  84. Apathy in Parkinson’s disease. A community-based study
    Kenn Freddy Pedersen · 2010 · NORA - Norwegian Open Research Archives
  85. Parkinson’s Disease: An Overview of Pathogenesis
    Pratap Chand, Irene Litvan · 2009 · Contemporary clinical neuroscience
  86. Syntheses of 8–(phenoxymethyl)caffeine analogues and their evaluation as inhibitors of monoamine oxidase and as antagonists of the adenosine A2A receptor
    Rozanne Harmse · 2013
  87. Occupational risk factors for Parkinson disease
    Marianne van der Mark · 2014 · Utrecht University Repository (Utrecht University)
  88. Additional file 1 of Occupational pesticide exposure and the risk of death in patients with Parkinson’s disease: an observational study in southern Brazil
    Schneider Medeiros, Márcio, P. Reddy, Sumanth, P. Socal, Mariana, Artur Francisco Schumacher‐Schuh, Mello Rieder, Carlos Roberto · 2020 · Figshare
  89. Additional file 1 of Patients with Parkinson’s disease predict a lower incidence of colorectal cancer
    Fang, Hongsheng, 杜芸兰, Pan, Shuting, Zhong, Ming, Tang, Jiayin · 2021 · Figshare
  90. Additional file 2 of Patients with Parkinson’s disease predict a lower incidence of colorectal cancer
    Fang, Hongsheng, 杜芸兰, Pan, Shuting, Zhong, Ming, Tang, Jiayin · 2021 · Figshare
  91. Maladie de Parkinson : physiopathologie, critères diagnostiques et signes cliniques
    A. Marques · 2025 · Encyclopédie médico-chirurgicale. Neurologie
  92. Chronic nicotine reduces nigral dopaminergic activity and remodels pedunculopontine cholinergic subpopulations
    Rita Yu-Tzu Chen, Hassan Hosseini, Skylar Hall, S. Zhang, Rebekah C. Evans · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  93. The relationship between herpesviruses and Parkinson’s disease: prevalence, viral load, and clinical implications
    Sare Madani, Kumars Amini, Seyed Amir Hassan Habibi, Mohammad Hassan Shahhosseiny, Taher Mohammadian · 2026 · Acta Virologica
  94. Etude de l'implication des cellules microgliales et de l'α-synucleine dans la maladie neurodégénérative de Parkinson
    Simon Moussaud · 2011
  95. Vulnérabilité des neurones dopaminergiques dans la maladie de Parkinson : rôle des afférences excitatrices des systèmes cholinergique pédonculopontin et orexinergique hypothalamique
    Manale Bensaid · 2014
  96. La dysarthrie dans la maladie de Parkinson : corrélats physiologiques, cognitifs et fonctionnels
    Cyril Atkinson-Clément · 2017
  97. Evaluation of the Dopaminergic System Using In Vivo PET Imaging and Post-Mortem Analyses in the Context of Mild Neurodegenerative and Neuroinflammatory PD Models
    Pauline Roost · 2020
  98. Étude génétique et corrélation génotype-phénotype de la maladie de Parkinson dans la population tunisienne
    Sawssan Ben Romdhan · 2019
  99. Mécanismes de compensation dans la maladie de Parkinson : approches comportementale, pharmacologique, de neuro-imagerie et immunohistochimique chez le singe intoxiqué au MPTP après récupération des symptômes moteurs
    Sara Neumane · 2011
  100. Contribution des interneurones cholinergiques striataux aux déficits cognitifs de la maladie de Parkinson : approches optogénétique et comportementale chez la souris
    Juliette Lhost · 2020